knowledge -WSS

knowledge

author：focus 2025-09-30 00:45:53 - browse：29691

Stoke Therapeutics is still seeking an effective dose for an experimental drug to treat a severe form of childhood epilepsy, following the release of updated data Tuesday that showed disappointing reductions in convulsive seizure activity.

In the latest look at an ongoing mid-stage study, three monthly injections of the Stoke drug, called STK-001, given at a 45-mg dose, resulted in a median 18% reduction in convulsive seizure activity, compared to baseline.

The new analysis was conducted on 16 children diagnosed with a rare form of epilepsy called Dravet syndrome. Last November, in six patients, the drug showed a median 55% reduction in seizure activity.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Cytokinetics CEO Robert Blum is on my Worst CEO shortlist again

knowledge

WSS

Updated Covid vaccine has 54% effectiveness, new study suggests

H5N1 bird flu outbreak: Second human case reported, in Michigan

Unique patient identifier: Experts argue the benefits, pitfalls

AstraZeneca stays mum on Medicare drug pricing negotiations

A protest over insulin prices is seen as a fight for life

Global cancer cases to surge 77% by 2050, WHO report says

hotspot

knowledge

leisure time

Cancer drug shortages should be causing more outrage

Eyeing GLP

What does generative AI mean for health care? We asked experts

A single Democrat is willing to weaken Medicare negotiation power

Walensky prepares to leave CDC — and Congress — behind

Gene therapy for Afghan refugees’ infant will be fully covered

Medical leaders decry Supreme Court decision on affirmative action

As a primary care physician, here's how I hope to partner with AI

Tori Bowie and the unacceptable rates of Black maternal death

Problems with a popular proposal to regulate AI in health care

hotspot

Reports of telehealth's death have been greatly exaggerated

Addressing health care workers' trauma can help fight burnout

Global cancer cases to surge 77% by 2050, WHO report says

Bernie brings in new pharma CEOs to talk drug prices

Cytokinetics CEO Robert Blum is on my Worst CEO shortlist again

Scrutiny of post

leisure time

knowledge

entertainment

focus